{
  "paper_id": "193942-V1",
  "package_path": "/Users/gabesekeres/Dropbox/Papers/competition_science/agentic_specification_search/data/downloads/extracted/193942-V1",
  "verified_at": "2026-02-03",
  "verifier": "verification_agent",
  "baseline_groups": [
    {
      "baseline_group_id": "G1",
      "claim_summary": "Gavi vaccine program introduction increases vaccine coverage rates in recipient countries.",
      "expected_sign": "+",
      "baseline_spec_ids": [
        "baseline"
      ],
      "baseline_outcome_vars": [
        "coverage"
      ],
      "baseline_treatment_vars": [
        "post"
      ],
      "notes": "Three-way FE (country-disease, cohort-disease, country-cohort), clustered at country. Coef=3.60pp, p<1e-7. Primary paper claim."
    },
    {
      "baseline_group_id": "G2",
      "claim_summary": "Gavi vaccine program introduction reduces child mortality rates.",
      "expected_sign": "-",
      "baseline_spec_ids": [
        "did/outcome/mortality_baseline"
      ],
      "baseline_outcome_vars": [
        "rate"
      ],
      "baseline_treatment_vars": [
        "post"
      ],
      "notes": "Mortality baseline shows POSITIVE coef (654.71, p=0.015), opposite of expected sign. Likely data reconstruction issue."
    }
  ],
  "global_notes": "Two main claims: (1) coverage increase (strongly supported), (2) mortality reduction (wrong sign in reconstructed data). Placebo test (BCG) shows significant positive effect, potentially undermining causal interpretation."
}